CREG [CHINA RECYCLING ENERGY] DEFA14A: (Original Filing)
[]
BITA [BITAUTO] 20-F: (Original Filing)
[] [EXECUTION VERSION YIXIN CAPITAL LIMITED SERIES C PREFERENCE SHARES SUBSCRIPTION AGREEMENT Dated as of May 11, 2017 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND TERMS 2 Section 1.1 Definitions 2 Section 1.2 Other Definitional Provisions 9 ARTICLE II PURCHASE AND SALE 10 Section 2.1 Sale and Is]
ZX [China Zenix Auto International] 20-F: (Original Filing)
[PART I 3 Item 1. Identity of Directors, Senior Management and Advisers 3 Item 2. Offer Statistics and Expected Timetable 3 Item 3. Key Information 3 Item 4. Information on the Company 27 Item 4A. Unresolved Staff Comments 52 Item 5. Operating and Financial Review and Prospects 52 Item 6. Directors, ]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Enters into Amendment to Amalgamation Agreement for
[Sinovac Enters into Amendment to Amalgamation Agreement for Going-Private Transaction Under the terms of the Amalgamation Agreement, the Amalgamation Agreement may be terminated by the Company or Parent if the amalgamation of Amalgamation Sub with and into the Company (the “Amalgamation”) has not oc]
SNP [CHINA PETROLEUM & CHEMICAL] IRANNOTICE: IRANNOTICE 1 a18-12310_1irannotice.htm IRANNOTICE
[IRANNOTICE 1 a18-12310_1irannotice.htm IRANNOTICE]
HSOL [Hanwha Q CELLS] 20-F:
[] [1. Hanwha SolarOne Investment Holding Ltd. (BVI) 2. Hanwha Q CELLS Corp. (Korea) 3. 4. Hanwha Q CELLS Hong Kong Limited (PRC) 5. Hanwha Q CELLS (Nantong) Co., Ltd. (PRC) 6. Hanwha Q CELLS Canada Corp. (Canada) 7. Hanwha Q CELLS (Qidong) Co., Ltd. (PRC) 8. Hanwha Q CELLS (Shanghai) Co., Ltd. (PRC)]
BITA [BITAUTO] 20-F:
[] [EXECUTION VERSION YIXIN CAPITAL LIMITED SERIES C PREFERENCE SHARES SUBSCRIPTION AGREEMENT Dated as of May 11, 2017 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND TERMS 2 Section 1.1 Definitions 2 Section 1.2 Other Definitional Provisions 9 ARTICLE II PURCHASE AND SALE 10 Section 2.1 Sale and Is]
ZX [China Zenix Auto International] 20-F: PART I 3 Item 1. Identity of Directors,
[PART I 3 Item 1. Identity of Directors, Senior Management and Advisers 3 Item 2. Offer Statistics and Expected Timetable 3 Item 3. Key Information 3 Item 4. Information on the Company 27 Item 4A. Unresolved Staff Comments 52 Item 5. Operating and Financial Review and Prospects 52 Item 6. Directors, ]
